GFAP and depressive symptom measurement: Interestingly, the expression of astrogliosis markers presented a more complex pattern with GFAP and aquaporin-4 (AQP4) levels being lower in MTLE patients with mental disorders and depression specifically, whereas Metallothioneins I/II (MT-I/II) levels being higher (Lu et al., 2019).